$ASTC
ASTROTECH Corp

2019 Q3 Form 10-Q Financial Statement

#000156459019043442 Filed on November 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q3
Revenue $0.00 $33.00K
YoY Change -100.0%
Cost Of Revenue $0.00 $11.00K
YoY Change -100.0%
Gross Profit $1.000K $22.00K
YoY Change -95.45%
Gross Profit Margin 66.67%
Selling, General & Admin $1.202M $1.144M
YoY Change 5.07% -18.69%
% of Gross Profit 120200.0% 5200.0%
Research & Development $855.0K $1.103M
YoY Change -22.48% -33.91%
% of Gross Profit 85500.0% 5013.64%
Depreciation & Amortization $141.0K $75.00K
YoY Change 88.0% -59.68%
% of Gross Profit 14100.0% 340.91%
Operating Expenses $2.057M $2.247M
YoY Change -8.46% -26.95%
Operating Profit -$2.056M -$2.225M
YoY Change -7.6% -27.67%
Interest Expense -$10.00K -$10.00K
YoY Change 0.0% -114.29%
% of Operating Profit
Other Income/Expense, Net -$12.00K -$13.00K
YoY Change -7.69% -118.57%
Pretax Income -$2.068M -$2.238M
YoY Change -7.6% -25.55%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.068M -$2.238M
YoY Change -7.6% -25.55%
Net Earnings / Revenue -6781.82%
Basic Earnings Per Share
Diluted Earnings Per Share -$370.3K -$550.4K
COMMON SHARES
Basic Shares Outstanding 5.924M 4.095M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.600M $1.900M
YoY Change -15.79% -81.37%
Cash & Equivalents $1.579M $1.906M
Short-Term Investments $0.00
Other Short-Term Assets $300.0K $300.0K
YoY Change 0.0% 50.0%
Inventory $300.0K $0.00
Prepaid Expenses
Receivables $0.00 $29.00K
Other Receivables $600.0K $0.00
Total Short-Term Assets $2.900M $2.205M
YoY Change 31.52% -79.23%
LONG-TERM ASSETS
Property, Plant & Equipment $1.900M $664.0K
YoY Change 186.14% -77.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $100.0K $81.00K
YoY Change 23.46% 0.0%
Total Long-Term Assets $2.200M $745.0K
YoY Change 195.3% -83.48%
TOTAL ASSETS
Total Short-Term Assets $2.900M $2.205M
Total Long-Term Assets $2.200M $745.0K
Total Assets $5.100M $2.950M
YoY Change 72.88% -80.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K $105.0K
YoY Change -4.76% -47.5%
Accrued Expenses $900.0K $800.0K
YoY Change 12.5% 109.42%
Deferred Revenue
YoY Change
Short-Term Debt $1.500M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.500M $946.0K
YoY Change 164.27% -5.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.300M $177.0K
YoY Change 634.46% -26.86%
Total Long-Term Liabilities $1.300M $177.0K
YoY Change 634.46% -26.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.500M $946.0K
Total Long-Term Liabilities $1.300M $177.0K
Total Liabilities $3.800M $1.123M
YoY Change 238.38% -9.44%
SHAREHOLDERS EQUITY
Retained Earnings -$186.4M
YoY Change 7.18%
Common Stock $190.6M
YoY Change 0.07%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.129M
YoY Change 0.12%
Treasury Stock Shares $399.9K
Shareholders Equity $1.300M $1.827M
YoY Change
Total Liabilities & Shareholders Equity $5.100M $2.950M
YoY Change 72.88% -80.5%

Cashflow Statement

Concept 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$2.068M -$2.238M
YoY Change -7.6% -25.55%
Depreciation, Depletion And Amortization $141.0K $75.00K
YoY Change 88.0% -59.68%
Cash From Operating Activities -$1.830M -$2.247M
YoY Change -18.56% -35.21%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $3.600M
YoY Change -100.0% 158.99%
Cash From Investing Activities $0.00 $3.595M
YoY Change -100.0% 160.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $321.0K $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.821M 6.000K
YoY Change 30250.0% -300.0%
NET CHANGE
Cash From Operating Activities -1.830M -2.247M
Cash From Investing Activities 0.000 3.595M
Cash From Financing Activities 1.821M 6.000K
Net Change In Cash -9.000K 1.354M
YoY Change -100.66% -164.82%
FREE CASH FLOW
Cash From Operating Activities -$1.830M -$2.247M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$1.830M -$2.247M
YoY Change -18.56% -35.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 us-gaap Gross Profit
GrossProfit
1000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1202000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
0
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
11000
CY2018Q3 us-gaap Gross Profit
GrossProfit
22000
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1144000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
855000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1103000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2068000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-2238000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5591000
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4073000
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
321000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
2057000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
2247000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2056000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2225000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2068000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2238000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
78000
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
26000
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-2068000
CY2019Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
7000
CY2018Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
31000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
44000
CY2018Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
14000
CY2018Q3 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
3000
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000
CY2018Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1000
CY2018Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
9000
CY2018Q3 us-gaap Profit Loss
ProfitLoss
-2238000
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
104000
CY2018Q3 us-gaap Share Based Compensation
ShareBasedCompensation
36000
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
141000
CY2018Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75000
CY2019Q3 us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
0
CY2018Q3 us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
-31000
CY2019Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
CY2018Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17000
CY2019Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1000
CY2018Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0
CY2019Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-61000
CY2018Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7000
CY2019Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-53000
CY2018Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
127000
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1830000
CY2018Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2247000
CY2019Q3 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0
CY2018Q3 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
3345000
CY2019Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0
CY2018Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
250000
CY2019Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2018Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3595000
CY2019Q3 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0
CY2018Q3 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
1000
CY2019Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1500000
CY2018Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2019Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2018Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7000
CY2019Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
321000
CY2018Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2019Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1821000
CY2018Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1354000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1588000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
552000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1579000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1906000
CY2019Q3 us-gaap Interest Paid Net
InterestPaidNet
0
CY2018Q3 us-gaap Interest Paid Net
InterestPaidNet
0
CY2019Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2018Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2019Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1608000
CY2018Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2019Q3 astc Number Of Patents Granted
NumberOfPatentsGranted
37
CY2019Q3 astc Number Of Additional Patents In Process
NumberOfAdditionalPatentsInProcess
5
CY2019Q3 astc Working Capital Deficit Surplus
WorkingCapitalDeficitSurplus
400000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-7500000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8500000
CY2018Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3000000
CY2019Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1400000
CY2019Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.11
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1608000
CY2019Q3 astc Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
81000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1541000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
292000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
414000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
425000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
434000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
258000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
188000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2011000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
470000
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
96000
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
324153
CY2019Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
2.83
CY2019Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
8.35
CY2019Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
324000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2019Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
324000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.71
CY2019Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2019Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.71
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
106000
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P7M9D
CY2019Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
324153
CY2019Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y6M21D
CY2019Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
5.71
CY2019Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
236075
CY2019Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
5.26
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2019Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
857000
CY2019 astc Tax Cuts And Jobs Act Of2017 Alternative Minimum Tax Credit Refund
TaxCutsAndJobsActOf2017AlternativeMinimumTaxCreditRefund
429000
CY2019Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
CY2018Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0
CY2019Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2

Files In Submission

Name View Source Status
0001564590-19-043442-index-headers.html Edgar Link pending
0001564590-19-043442-index.html Edgar Link pending
0001564590-19-043442.txt Edgar Link pending
0001564590-19-043442-xbrl.zip Edgar Link pending
astc-10q_20190930.htm Edgar Link pending
astc-20190930.xml Edgar Link completed
astc-20190930.xsd Edgar Link pending
astc-20190930_cal.xml Edgar Link unprocessable
astc-20190930_def.xml Edgar Link unprocessable
astc-20190930_lab.xml Edgar Link unprocessable
astc-20190930_pre.xml Edgar Link unprocessable
astc-ex311_7.htm Edgar Link pending
astc-ex312_6.htm Edgar Link pending
astc-ex321_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gvbsmgzd01dr000001.jpg Edgar Link pending
gvbsmgzd01dr000002.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending